Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeadlam Regulatory News (HEAD)

Share Price Information for Headlam (HEAD)

Share Price is delayed by 15 minutes
Get Live Data
28.40    -1.00 (-3.40%)
Bid:
28.10
Ask:
28.30
Spread: 0.20 (0.712%)
Market Cap: £22.80m
HEAD Live PriceLast checked at - London Stock Exchange

Intraday Headlam Share Chart

Executive Appointments

3 Mar 2026 07:00

RNS Number : 0151V
Headlam Group PLC
03 March 2026
 

 3rd March 2026

Headlam Group plc

('Headlam', the 'Company', the 'Group')

Executive appointments

Headlam (LSE: HEAD), the UK's leading floor coverings distributor, is pleased to announce two important appointments.

 

Rob Barclay will join the Board of Headlam as Designate Chief Executive Officer, effective 9 March 2026. Initially, Rob will spend his time with the sales team and customers before assuming full responsibility as Chief Executive Officer on 27 April 2026 when Stephen Bird, Interim Executive Chairman will return to his role as a Non-Executive Chair.

 

Rob brings more than 25 years of leadership track record in building products manufacturing and distribution businesses, including relevant flooring experience, as well as leading transformation programmes and delivering operational excellence. Rob's experience includes [senior leadership] roles at SIG plc, National Timber Group Ltd and most recently Batt Cables Ltd. Rob's deep understanding of specialist distribution, complex supply chains, and customer dynamics positions him well to lead the business through its next phase of development. Rob will work closely with the leadership team to build on the company's market position and to further improve service levels and value to customers across the UK.

 

Secondly, Richard Jones will join the Group as Interim Chief Financial Officer (CFO), effective 12 March 2026. Richard most recently joins from HSS Hire Group Plc (recently renamed ProService Building Services Marketplace Plc) where he was also Interim CFO, a role he held since 2024. Prior to this, over the past decade, he has held senior finance positions at Medica Group Ltd, Mereo Biopharma Plc and Shield Therapeutics Plc. Richard has a proven track record in building high performing finance teams and driving corporate strategy. He will undertake an orderly handover transition with Adam Phillips, the current CFO, after which Richard will also be appointed a Board Director.

 

Commenting on his appointment, Rob Barclay said:

 

"I'm excited to be joining a company with a long history and a clear plan for improvement at such an important time in its journey. My priority will be to listen and learn, be clear on what drives our success, and work with the team to deliver this."

 

Commenting, Stephen Bird, Interim Executive Chairman, said:

 

"I am delighted to welcome both Rob and Richard to the Group. Under Rob's leadership, we will seek to drive through the strategic focus and organisational enhancements required for the next phase of our development."

 

 

For the purposes of UKLR 6.4.8, Rob was previously a Non-Executive Director of Speedy Hire plc, and the Chief Executive Officer of Batt Cables Limited and its holding company Cricket Bidco Limited (both of which entered into administration on 6 January 2026) from 27 January 2025 to 26 February 2026. Richard is currently a Non-Executive Director of Inspiration Healthcare plc, and previously was an Executive Director of HSS Hire Group plc (recently renamed ProService Building Services Marketplace plc) and Medica Group plc, and previously was a Non-Executive Director of Alliance Pharma plc. There is no further information that is required to be disclosed under UKLR 6.4.8.

 

Enquiries

 

 

Headlam Group plc

Tel: 01675 433 000

Stephen Bird, Interim Executive Chairman

Email: headlamgroup@headlam.com

 

Panmure Liberum Limited (Corporate Broker)

 

Tom Scrivens / Atholl Tweedie

Tel: 020 3100 2000

 

 

 

Notes to Editors

Operating for over 30 years, Headlam is the UK's leading floorcoverings distributor. The Group works with suppliers across the globe manufacturing the broadest range of products, and gives them a highly effective route to market, selling their products into the large and diverse trade customer base. The Group has an extensive customer base, providing them with a market leading service through the largest product range, in-depth knowledge, ecommerce and marketing support, and nationwide delivery service. To maximise customer reach and sales opportunity, Headlam operates businesses, trade brands and product brands across the UK and Continental Europe (France and the Netherlands), which are supported by the group's network, central resources and processes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPDAEFKKEFA
Date   Source Headline
3rd May 20227:00 amRNSTransaction in Own Shares
29th Apr 20223:46 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSTransaction in Own Shares
28th Apr 20227:00 amRNSTransaction in Own Shares
27th Apr 20227:00 amRNSTransaction in Own Shares
26th Apr 20227:00 amRNSTransaction in Own Shares
25th Apr 20227:00 amRNSTransaction in Own Shares
22nd Apr 20227:00 amRNSTransaction in Own Shares
20th Apr 20227:00 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
14th Apr 20227:00 amRNSTransaction in Own Shares
12th Apr 20227:00 amRNSTransaction in Own Shares
8th Apr 20221:21 pmRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSTransaction in Own Shares
5th Apr 20227:00 amRNSTransaction in Own Shares
4th Apr 202210:30 amRNSReplacement: Transaction in Own Shares
4th Apr 20227:00 amRNSTransaction in Own Shares
1st Apr 202212:08 pmRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSTransaction in Own Shares
31st Mar 20229:57 amRNSTotal Voting Rights
31st Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:30 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20229:55 amRNSAnnual Report and Accounts and Notice of AGM
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20227:30 amRNSTransaction in Own Shares
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:02 amRNSShare Buyback Programme
9th Mar 20227:00 amRNSFinal Results
8th Mar 20227:00 amRNSBoard Changes
1st Mar 20223:49 pmRNSOption Exercise and Transfer of Treasury Shares
28th Feb 202210:41 amRNSTotal Voting Rights
16th Feb 20227:00 amRNSNotice of Final Results and Investor Presentation
14th Feb 20223:36 pmRNSOption Exercise and Transfer of Treasury Shares
1st Feb 20222:50 pmRNSOption Exercise and Transfer of Treasury Shares
31st Jan 20229:42 amRNSTotal Voting Rights
27th Jan 20227:00 amRNSPre-Close Trading Update
19th Jan 20224:16 pmRNSOption Exercise and Transfer of Treasury Shares
4th Jan 20225:18 pmRNSExercise of share options / Transfer of shares
31st Dec 20217:00 amRNSTotal Voting Rights
22nd Dec 202112:33 pmRNSOption Exercise and Transfer of Treasury Shares
14th Dec 20217:00 amRNSAppointment of Joint Broker
7th Dec 20213:35 pmRNSOption Exercise and Transfer of Treasury Shares
30th Nov 202111:36 amRNSTotal Voting Rights
25th Nov 20217:00 amRNSESG and Trading Update
24th Nov 20213:45 pmRNSOption Exercise and Transfer of Treasury Shares
10th Nov 202111:31 amRNSOption Exercise and Transfer of Treasury Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.